{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:17:51Z","timestamp":1792513071805,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00244520"],"award-info":[{"award-number":["RS-2023-00244520"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04285-w","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T13:01:42Z","timestamp":1712581302000},"page":"3036-3044","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction"],"prefix":"10.1007","volume":"49","author":[{"given":"Hee Jun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6893-3136","authenticated-orcid":false,"given":"Sunyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"4285_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"1","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15(1):11-20. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1038\/nrgastro.2017.109","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"4285_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA (2022) The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 7(9):851-861. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/s2468-1253(22)00165-0","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"4285_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1):328-357. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"issue":"2","key":"4285_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/life11020119","volume":"11","author":"S Emhmed Ali","year":"2021","unstructured":"Emhmed Ali S, Nguyen MH (2021) Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease-The Union of Two Culprits. Life (Basel) 11(2): 119. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.3390\/life11020119","journal-title":"Life (Basel)"},{"issue":"4","key":"4285_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3350\/cmh.2022.0070","volume":"28","author":"CH Ng","year":"2022","unstructured":"Ng CH, Huang DQ, Nguyen MH (2022) Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name. Clin Mol Hepatol 28(4):790-801. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.3350\/cmh.2022.0070","journal-title":"Clin. Mol. Hepatol."},{"issue":"6","key":"4285_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW, et al. (2020) The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int 14(6):889-919. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/s12072-020-10094-2","journal-title":"Hepatol. Int."},{"issue":"1","key":"4285_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al. (2020) A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 73(1):202-209. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","journal-title":"J. Hepatol."},{"issue":"9","key":"4285_CR8","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/liv.14548","volume":"40","author":"S Lin","year":"2020","unstructured":"Lin S, Huang J, Wang M, Kumar R, Liu Y, Liu S, Wu Y, Wang X, Zhu Y (2020) Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver Int 40(9):2082-2089. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1111\/liv.14548","journal-title":"Liver Int."},{"issue":"1","key":"4285_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.14218\/jcth.2021.00089","volume":"10","author":"C Yu","year":"2022","unstructured":"Yu C, Wang M, Zheng S, Xia M, Yang H, Zhang D, Yin C, Cheng N, Bai Y (2022) Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study. J Clin Transl Hepatol 10(1):6-16. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.14218\/jcth.2021.00089","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"3","key":"4285_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.cgh.2021.11.038","volume":"21","author":"GEH Lim","year":"2023","unstructured":"Lim GEH, Tang A, Ng CH, et al. (2023) An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD. Clin Gastroenterol Hepatol 21(3):619-629.e617. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.cgh.2021.11.038","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"12","key":"4285_CR11","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/liv.14675","volume":"40","author":"S Yamamura","year":"2020","unstructured":"Yamamura S, Eslam M, Kawaguchi T, Tsutsumi T, Nakano D, Yoshinaga S, Takahashi H, Anzai K, George J, Torimura T (2020) MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int 40(12):3018-3030. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1111\/liv.14675","journal-title":"Liver Int."},{"issue":"2","key":"4285_CR12","doi-asserted-by":"publisher","first-page":"e0245762","DOI":"10.1371\/journal.pone.0245762","volume":"16","author":"MA Niriella","year":"2021","unstructured":"Niriella MA, Ediriweera DS, Kasturiratne A, De Silva ST, Dassanayaka AS, De Silva AP, Kato N, Pathmeswaran A, Wickramasinghe AR, de Silva HJ (2021) Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study. PLoS One 16(2):e0245762. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1371\/journal.pone.0245762","journal-title":"PLoS ONE"},{"issue":"10","key":"4285_CR13","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1007\/s10620-022-07508-6","volume":"67","author":"H Kim","year":"2022","unstructured":"Kim H, Lee CJ, Ahn SH, Lee KS, Lee BK, Baik SJ, Kim SU, Lee JI (2022) MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups. Dig Dis Sci 67(10):4919-4928. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/s10620-022-07508-6","journal-title":"Dig. Dis. Sci."},{"key":"4285_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. (2023) A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003","journal-title":"J. Hepatol."},{"key":"4285_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000520","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. (2023) A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1097\/hep.0000000000000520","journal-title":"Hepatology"},{"issue":"6","key":"4285_CR16","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/hep.26455","volume":"58","author":"M Noureddin","year":"2013","unstructured":"Noureddin M, Lam J, Peterson MR, et al. (2013) Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 58(6):1930-1940. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1002\/hep.26455","journal-title":"Hepatology"},{"issue":"6","key":"4285_CR17","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/hep.26543","volume":"58","author":"SB Reeder","year":"2013","unstructured":"Reeder SB (2013) Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis. Hepatology 58(6):1877-1880. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1002\/hep.26543","journal-title":"Hepatology"},{"issue":"3","key":"4285_CR18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/hep.25731","volume":"56","author":"TA Le","year":"2012","unstructured":"Le TA, Chen J, Changchien C, et al. (2012) Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 56(3):922-932. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1002\/hep.25731","journal-title":"Hepatology"},{"issue":"4","key":"4285_CR19","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/hep.27647","volume":"61","author":"R Loomba","year":"2015","unstructured":"Loomba R, Sirlin CB, Ang B, et al. (2015) Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 61(4):1239-1250. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1002\/hep.27647","journal-title":"Hepatology"},{"issue":"3","key":"4285_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1148\/radiol.13121360","volume":"267","author":"IS Idilman","year":"2013","unstructured":"Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, Celik A, Bahar K, Karcaaltincaba M (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267(3):767-775. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1148\/radiol.13121360","journal-title":"Radiology"},{"issue":"5","key":"4285_CR21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jhep.2016.06.005","volume":"65","author":"PS Dulai","year":"2016","unstructured":"Dulai PS, Sirlin CB, Loomba R (2016) MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. J Hepatol 65(5):1006-1016. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jhep.2016.06.005","journal-title":"J. Hepatol."},{"issue":"2","key":"4285_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/hep.29797","volume":"68","author":"C Caussy","year":"2018","unstructured":"Caussy C, Reeder SB, Sirlin CB, Loomba R (2018) Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials. Hepatology 68(2):763-772. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1002\/hep.29797","journal-title":"Hepatology"},{"issue":"3","key":"4285_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/apt.15626","volume":"51","author":"KA Kang","year":"2020","unstructured":"Kang KA, Jun DW, Kim MS, Kwon HJ, Nguyen MH (2020) Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check-up clinic population. Aliment Pharmacol Ther 51(3):388- doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1111\/apt.15626","journal-title":"Aliment Pharmacol. Ther."},{"issue":"5","key":"4285_CR24","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/hep.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, Kleiner DE, Loomba R (2023) AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77(5):1797-1835. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1097\/hep.0000000000000323","journal-title":"Hepatology"},{"issue":"3","key":"4285_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3350\/cmh.2013.19.3.266","volume":"19","author":"EH Jeong","year":"2013","unstructured":"Jeong EH, Jun DW, Cho YK, Choe YG, Ryu S, Lee SM, Jang EC (2013) Regional prevalence of non- alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea. Clin Mol Hepatol 19(3):266-272. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.3350\/cmh.2013.19.3.266","journal-title":"Clin. Mol. Hepatol."},{"issue":"18","key":"4285_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3238\/arztebl.2018.0309","volume":"115","author":"H Andresen-Streichert","year":"2018","unstructured":"Andresen-Streichert H, M\u00fcller A, Glahn A, Skopp G, Sterneck M (2018) Alcohol Biomarkers in Clinical and Forensic Contexts. Dtsch Arztebl Int 115(18):309-315. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.3238\/arztebl.2018.0309","journal-title":"Dtsch Arztebl Int."},{"issue":"4","key":"4285_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MOL.0b013e3283606845","volume":"24","author":"B Klop","year":"2013","unstructured":"Klop B, do Rego AT, Cabezas MC (2013) Alcohol and plasma triglycerides. Curr Opin Lipidol 24(4):321-326. doi: https:\/\/doi.org\/https:\/\/doi.org\/10.1097\/MOL.0b013e3283606845","journal-title":"Curr. Opin Lipidol."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04285-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04285-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04285-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T14:52:24Z","timestamp":1724338344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04285-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["4285"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04285-w","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"assertion":[{"value":"7 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research study was conducted retrospectively from data obtained for clinical purposes. This study was approved by the institutional review board of our institution and the requirement for written informed consent was waived due to the retrospective nature of the analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}